Disclosure under regulation 30 of the SEBI (LODR) Regulations for resigantion of Director
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has informed BSE that Mrs. Brij Bala Gupta, a Director on the Board, has resigned with effect from 25 November 2025, citing pre-occupation and certain unavoidable circumstances. She was not a member of any board committee. The company has confirmed there are no other material reasons for the resignation beyond those stated in the letter. The resignation letter will be tabled at the next Board meeting for record.
This is a routine non-executive board-level change with no stated governance concerns or operational implications. Shareholders are unlikely to see a material impact on the stock or business from this disclosure alone.